Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2026-03-11 @ 9:03 PM
Study NCT ID:
NCT02314520
Status:
COMPLETED
Last Update Posted:
2017-07-19
First Post:
2014-11-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Complications Associated With Central Venous Access in the NSICU: PICC vs CVC
Sponsor:
Milton S. Hershey Medical Center
Organization:
Study Overview
Official Title:
Complications Associated With Central Venous Access in the NSICU: PICC vs CVC
Status:
COMPLETED
Status Verified Date:
2017-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NSPVC
Brief Summary:
The goal of this study is to determine whether Peripherally Inserted Central Catheter or Centrally Inserted Venous Catheters have lower complication rates in the Neuroscience Intensive Care Unit. After admission to the Neuroscience ICU and if they require central access, patients will be randomized to receive a PICC or CVC and complications (such as pneumothorax, deep venous thrombosis, infection, etc.) will be tracked and compared between the two interventions.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: